Dubash 1
Dubash 1 PDF 79Kb
Personalising care: using infliximab drug trough and anti-drug antibody levels is a safe and cost effective treatment strategy in Spondyloarthritis
S.Dubash1,2, J Fitton1,2, D Bryer1, A Barr1,2, C Vandevelde1,2, H Marzo-Ortega1,2, JE Freeston1,2
LeedsInstitute of Rheumatic and Musculoskeletal Medicine, University of Leeds
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust
Jane Freeston to present